Search in:
Matthew Meier
Biography:
Matt Meier received his B.A. from the University of Kansas and Psy.D. from Forest Institute of Professional Psychology. He is a licensed psychologist and has served as a clinical director in multiple community mental health and substance abuse treatment centers. Dr. Meier is the Associate Director of Clinical Training and a supervisor at the Clinical Psychology Center. He also supervises an Integrated Health-Behavioral Health program at ASU Health Services. Dr. Meier’s clinical focus in on the treatment of co-occurring mental and substance use disorders. This interest has evolved into a focus on transdiagnostic treatment approaches, and Dr. Meier is currently conducting research at the Phoenix VA on a fully transdiagnostic, open-enrollment group treatment.
Education:
B.A., University of Kansas, 1997
M.A., Forest Institute of Professional Psychology, 2004
Psy.D., Forest Institute of Professional Psychology, 2006
Research Website URL:
Research Interests:
My area of expertise is in the treatment of co-occurring mental and substance use disorders. This interest has evolved into a focus on transdiagnostic treatment approaches. I have developed a cognitive-behavioral transdiagnostic group treatment that addresses unmet needs in community mental health settings -- evidence-based practices that can treat comorbidity in a continous enrollment, group therapy format. This treatment is currently being piloted at the Phoenix VA.
Additional interests include dissimination and implementation research, treatment outcome evaluation, and the effectiveness of behavioral health services in Integrated Health settings. I also provide clinical supervision for an ongoing implementation and dissemination grant studying an adolescent drug abuse prevention program, Optimizing a Drug Abuse Prevention Program for Dissemination. HHS-NIH-NIDA(6/15/2014 - 5/31/2019).
Publications:
Meier, M. A., & Meier, M. H. (2017). Clinical implications of a general psychopathology factor: A cognitive-behavioral transdiagnostic group treatment for community mental health. Journal of Psychotherapy Integration. Advance online publication. http://dx.doi.org/10.1037/int0000095
| Spring 2022 | |
|---|---|
| Course Number | Course Title |
| PSY 399 | Supervised Research |
| PSY 499 | Individualized Instruction |
| PSY 570 | Psychopharmacology |
| PSY 680 | Practicum |
| Fall 2021 | |
|---|---|
| Course Number | Course Title |
| PSY 399 | Supervised Research |
| PSY 499 | Individualized Instruction |
| PSY 602 | Comorbidity Substance Use |
| PSY 680 | Practicum |
| Summer 2021 | |
|---|---|
| Course Number | Course Title |
| PSY 603 | Evidence-Based Interventions |
| Spring 2021 | |
|---|---|
| Course Number | Course Title |
| PSY 570 | Psychopharmacology |
| PSY 603 | Evidence-Based Interventions |
| PSY 604 | Multicultural Issues |
| PSY 680 | Practicum |
| Fall 2020 | |
|---|---|
| Course Number | Course Title |
| PSY 472 | Clinical Psychology |
| PSY 591 | Seminar |
| PSY 601 | Assessment & Diagnosis |
| PSY 602 | Comorbidity Substance Use |
| PSY 605 | Grp Thrpy for Subst Rel Probl |
| PSY 680 | Practicum |
| Summer 2020 | |
|---|---|
| Course Number | Course Title |
| PSY 603 | Evidence-Based Interventions |
| Spring 2020 | |
|---|---|
| Course Number | Course Title |
| PSY 472 | Clinical Psychology |
| PSY 570 | Psychopharmacology |
| PSY 603 | Evidence-Based Interventions |
| PSY 604 | Multicultural Issues |
| Fall 2019 | |
|---|---|
| Course Number | Course Title |
| PSY 366 | Abnormal Psychology |
| PSY 602 | Comorbidity Substance Use |
| Fall 2018 | |
|---|---|
| Course Number | Course Title |
| PSY 366 | Abnormal Psychology |
| Spring 2018 | |
|---|---|
| Course Number | Course Title |
| PSY 780 | Practicum |
| Fall 2017 | |
|---|---|
| Course Number | Course Title |
| PSY 394 | Special Topics |